Integrated Advisors Network’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Integrated Advisors Network’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-9,084	Closed	-$979K	–	715
2021 Q4	$979K	Buy	9,084 +47	+0.5%	+$5.13K	0.06%	290
2021 Q3	$990K	Buy	9,037 +910	+11%	+$94.5K	0.07%	257
2021 Q2	$761K	Buy	8,127 +402	+5%	+$37K	0.06%	275
2021 Q1	$711K	Buy	7,725 +3,415	+79%	+$288K	0.07%	259
2020 Q4	$315K	Sell	4,310 -152	-3%	-$11.3K	0.03%	380
2020 Q3	$347K	Sell	4,462 -2,386	-35%	-$164K	0.04%	319
2020 Q2	$381K	Buy	+6,848	New	+$293K	0.04%	300
2020 Q1	–	Sell	-6,476	Closed	-$234K	–	469
2019 Q4	$234K	Buy	+6,476	New	+$199K	0.03%	368

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Integrated Advisors Network's HZNP Position: Q1 2022 in Review

Integrated Advisors Network sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q1 2022, closing a stake of 9,084 shares — an estimated $979K sold.

Integrated Advisors Network first reported a position in HZNP in Q4 2019 and held it in 8 quarters. The position peaked at $990K in Q3 2021. 620 funds tracked by Wall St. Rank hold HZNP as of Q1 2022.

Integrated Advisors Network reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q1 2022 after selling out during the quarter.
Integrated Advisors Network sold 9,084 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q1 2022, an estimated $979K.
Integrated Advisors Network first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2019 and held it in 8 quarters.
Integrated Advisors Network's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $990K in Q3 2021.
620 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q1 2022.

Based on Integrated Advisors Network's 13F filing for Q1 2022, filed 2 May 2022.